«FITOFARM» is a dynamically developing company, which is included in the TOP-10 pharmaceutical companies of Ukraine in the packs, announces a new round of business development.
With the beginning of the new business season in September 2019, PrJSC «FITOFARM» underwent a number of positive changes – the company approved the new development strategy for 2020-2024, and also strengthened its team.
The post of General Director of PrJSC «FITOFARM» was taken by Mr. Vladyslav Malynin, formerly Director of the Direct Investment Fund at Astrolax Invest LLC, and before that, he worked as a financial director of the Ukrainian Media Holding UMH Group, financial director and member of the Management Board at Veres Group. Mr. Malynin experience in the pharmaceutical industry is 5 years.
In addition, Commercial Director Mr. Volodymyr Kvashuk joined the team. Before joining FITOFARM, he was the head of the prescription drug department at Sandoz Ukraine, and previously held the position of head of sales at Ipsen Ukraine and marketing coordinator at Pfizer Ukraine. Mr. Kvashyk has over 15 years of experience in the pharmaceutical industry.
In the near future, new successful professionals from large domestic and international companies will also join the team of the company.
«FITOFARM» plans to launch the new products that will become the best sellers of the pharmaceutical market, expand its geographic presence and open new lines of business.
«FITOFARM» is always open for any productive cooperation, — Mr. Vladyslav Malynin comments. —Respecting our partners and consumers, we will continue to produce products of exceptionally high quality, provide timely and complete information about our products, and strictly comply with contractual obligations. We value our business partners, our old and new friends, and wish us new joint projects and fruitful cooperation!»
This news was also published in the leading edition of Ukraine for specialists in the field of pharmacy and medicine, the newspaper “Weekly Pharmacy” and the online version of the publication at the link: https://www.apteka.ua/article/516694